Acute coronary syndrome, monitoring patients with

Devise a pharmacotherapy treatment and monitoring plan for a patient with non-ST-segment elevation acute coronary syndrome given patient-specific data. [Pg.83]

Formulate a monitoring plan for a patient with ST-segment elevation acute coronary syndrome receiving fibrinolytics, aspirin, unfractionated heparin, intravenous nitroglycerin, intravenous (3-blockers followed by oral P-blockers, an angiotensin-converting enzyme inhibitor, and a statin. [Pg.83]

Akkerhuis KM, Klootwijd PA, Lindeboom W et al. Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events meta-analysis of three studies involving 995 patients. Eur Heart J 2001 22 1997. [Pg.310]

Specific leads may also be used in monitoring patients with acute coronary syndromes. [Pg.280]